• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性吗啡治疗期间中枢杏仁核 GABA 能传递的神经适应。

Neuroadaptation of GABAergic transmission in the central amygdala during chronic morphine treatment.

机构信息

Molecular and Integrative Neurosciences Department, The Scripps Research Institute, La Jolla, CA 92037, USA.

出版信息

Addict Biol. 2011 Oct;16(4):551-64. doi: 10.1111/j.1369-1600.2010.00269.x. Epub 2010 Dec 23.

DOI:10.1111/j.1369-1600.2010.00269.x
PMID:21182569
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3117063/
Abstract

We investigated possible alterations of pharmacologically-isolated, evoked GABA(A) inhibitory postsynaptic potentials (eIPSPs) and miniature GABA(A) inhibitory postsynaptic currents (mIPSCs) in the rat central amygdala (CeA) elicited by acute application of µ-opioid receptor (MOR) agonists (DAMGO and morphine; 1 µM) and by chronic morphine treatment with morphine pellets. The acute activation of MORs decreased the amplitudes of eIPSPs, increased paired-pulse facilitation (PPF) of eIPSPs and decreased the frequency (but not the amplitude) of mIPSCs in a majority of CeA neurons, suggesting that acute MOR-dependent modulation of this GABAergic transmission is mediated predominantly via presynaptic inhibition of GABA release. We observed no significant changes in the membrane properties, eIPSPs, PPF or mIPSCs of CeA neurons during chronic morphine treatment compared to CeA of naïve or sham rats. Superfusion of the MOR antagonist CTOP (1 µM) increased the mean amplitude of eIPSPs in a majority of CeA neurons to the same degree in both naïve/sham and morphine-treated rats, suggesting a tonic activation of MORs in both conditions. Superfusion of DAMGO decreased eIPSP amplitudes and the frequency of mIPSCs equally in both naïve/sham and morphine-treated rats but decreased the amplitude of mIPSCs only in morphine treated rats, an apparent postsynaptic action. Our combined findings suggest the development of tolerance of the CeA GABAergic system to inhibitory effects of acute activation of MORs on presynaptic GABA release and possible alteration of MOR-dependent postsynaptic mechanisms that may represent important neuroadaptations of the GABAergic and MOR systems during chronic morphine treatment.

摘要

我们研究了在大鼠杏仁中央核(CeA)中,急性应用μ-阿片受体(MOR)激动剂(DAMGO 和吗啡;1 μM)和慢性吗啡贴片处理对药理学分离的、诱发的 GABA(A) 抑制性突触后电位(eIPSP)和微小 GABA(A) 抑制性突触后电流(mIPSCs)可能产生的改变。MOR 的急性激活降低了 eIPSP 的幅度,增加了 eIPSP 的成对脉冲易化(PPF),并降低了 mIPSCs 的频率(但不影响幅度),这表明急性 MOR 依赖性对这种 GABA 能传递的调制主要通过 GABA 释放的突触前抑制来介导。与未处理或假处理的大鼠的 CeA 相比,在慢性吗啡处理期间,我们没有观察到 CeA 神经元的膜特性、eIPSP、PPF 或 mIPSCs 发生显著变化。MOR 拮抗剂 CTOP(1 μM)的灌流使大多数 CeA 神经元的 eIPSP 平均幅度在未处理/假处理和吗啡处理的大鼠中增加到相同程度,这表明在两种情况下 MOR 都处于紧张激活状态。DAMGO 的灌流以相同的程度降低了未处理/假处理和吗啡处理的大鼠中 eIPSP 的幅度和 mIPSCs 的频率,但仅降低了吗啡处理的大鼠中 mIPSCs 的幅度,这是一种明显的突触后作用。我们的综合发现表明,CeA GABA 能系统对 MOR 急性激活对突触前 GABA 释放的抑制作用产生了耐受性,并且可能改变了 MOR 依赖性的突触后机制,这可能代表了慢性吗啡处理期间 GABA 能和 MOR 系统的重要神经适应。

相似文献

1
Neuroadaptation of GABAergic transmission in the central amygdala during chronic morphine treatment.慢性吗啡治疗期间中枢杏仁核 GABA 能传递的神经适应。
Addict Biol. 2011 Oct;16(4):551-64. doi: 10.1111/j.1369-1600.2010.00269.x. Epub 2010 Dec 23.
2
Mu-opioid-mediated inhibition of glutamate synaptic transmission in rat central amygdala neurons.μ-阿片类物质介导的对大鼠中央杏仁核神经元谷氨酸突触传递的抑制作用。
Neuroscience. 2005;133(1):97-103. doi: 10.1016/j.neuroscience.2005.02.004.
3
Activation of mu-opioid receptors in the ventrolateral orbital cortex inhibits the GABAergic miniature inhibitory postsynaptic currents in rats.腹外侧眶额皮质中μ-阿片受体的激活会抑制大鼠体内的γ-氨基丁酸能微小抑制性突触后电流。
Neurosci Lett. 2015 Apr 10;592:64-9. doi: 10.1016/j.neulet.2015.02.045. Epub 2015 Feb 21.
4
Mu opioid receptor activation inhibits GABAergic inputs to basolateral amygdala neurons through Kv1.1/1.2 channels.μ阿片受体激活通过Kv1.1/1.2通道抑制向基底外侧杏仁核神经元的GABA能输入。
J Neurophysiol. 2006 Apr;95(4):2032-41. doi: 10.1152/jn.01004.2005. Epub 2005 Nov 23.
5
Ethanol dually modulates GABAergic synaptic transmission onto dopaminergic neurons in ventral tegmental area: role of mu-opioid receptors.乙醇双重调节腹侧被盖区多巴胺能神经元上的GABA能突触传递:μ-阿片受体的作用。
Neuroscience. 2008 Apr 22;153(1):240-8. doi: 10.1016/j.neuroscience.2008.01.040. Epub 2008 Feb 6.
6
Effect of the {mu} opioid on excitatory and inhibitory synaptic inputs to periaqueductal gray-projecting neurons in the amygdala.μ阿片类物质对杏仁核中导水管周围灰质投射神经元的兴奋性和抑制性突触输入的影响。
J Pharmacol Exp Ther. 2005 Feb;312(2):441-8. doi: 10.1124/jpet.104.074633. Epub 2004 Sep 23.
7
Direct actions of cannabinoids on synaptic transmission in the nucleus accumbens: a comparison with opioids.大麻素对伏隔核突触传递的直接作用:与阿片类药物的比较。
J Neurophysiol. 2001 Jan;85(1):72-83. doi: 10.1152/jn.2001.85.1.72.
8
Glycine and GABAA receptor-mediated synaptic transmission in rat substantia gelatinosa: inhibition by mu-opioid and GABAB agonists.甘氨酸和GABAA受体介导的大鼠脊髓背角胶状质突触传递:μ-阿片类和GABAB激动剂的抑制作用
J Physiol. 1998 Mar 1;507 ( Pt 2)(Pt 2):473-83. doi: 10.1111/j.1469-7793.1998.473bt.x.
9
Repeated morphine treatment alters cannabinoid modulation of GABAergic synaptic transmission within the rat periaqueductal grey.反复给予吗啡治疗会改变大麻素对大鼠中脑导水管周围灰质内GABA能突触传递的调节作用。
Br J Pharmacol. 2015 Jan;172(2):681-90. doi: 10.1111/bph.12809. Epub 2014 Sep 5.
10
Contribution of adenylyl cyclase modulation of pre- and postsynaptic GABA neurotransmission to morphine antinociception and tolerance.腺苷酸环化酶对突触前和突触后γ-氨基丁酸(GABA)神经传递的调节对吗啡镇痛及耐受性的作用。
Neuropsychopharmacology. 2014 Aug;39(9):2142-52. doi: 10.1038/npp.2014.62. Epub 2014 Mar 13.

引用本文的文献

1
Pain-related cortico-limbic plasticity and opioid signaling.疼痛相关的皮质-边缘可塑性和阿片类信号传导。
Neuropharmacology. 2023 Jun 15;231:109510. doi: 10.1016/j.neuropharm.2023.109510. Epub 2023 Mar 20.
2
Opioid Receptor-Mediated Regulation of Neurotransmission in the Brain.阿片受体介导的大脑神经传递调节
Front Mol Neurosci. 2022 Jun 15;15:919773. doi: 10.3389/fnmol.2022.919773. eCollection 2022.
3
Addiction-induced plasticity in underlying neural circuits.成瘾导致的潜在神经回路可塑性。

本文引用的文献

1
Cell-dependent physiological synaptic action of morphine in the rat habenular nucleus: morphine both inhibits and facilitates excitatory synaptic transmission.吗啡在大鼠缰核中依赖细胞的生理性突触作用:吗啡既能抑制又能促进兴奋性突触传递。
Neurosci Lett. 2009 Feb 27;451(3):270-3. doi: 10.1016/j.neulet.2009.01.009. Epub 2009 Jan 13.
2
Mu-opioid receptors selectively regulate basal inhibitory transmission in the central amygdala: lack of ethanol interactions.μ-阿片受体选择性调节中央杏仁核的基础抑制性突触传递:缺乏乙醇相互作用。
J Pharmacol Exp Ther. 2009 Jan;328(1):284-93. doi: 10.1124/jpet.108.140749. Epub 2008 Oct 14.
3
Neurol Sci. 2022 Mar;43(3):1605-1615. doi: 10.1007/s10072-021-05778-y. Epub 2022 Jan 22.
4
Self-Administration of Entactogen Psychostimulants Dysregulates Gamma-Aminobutyric Acid (GABA) and Kappa Opioid Receptor Signaling in the Central Nucleus of the Amygdala of Female Wistar Rats.在雌性Wistar大鼠杏仁核中央核中,致幻型精神兴奋剂的自我给药会失调γ-氨基丁酸(GABA)和κ阿片受体信号传导。
Front Behav Neurosci. 2021 Dec 16;15:780500. doi: 10.3389/fnbeh.2021.780500. eCollection 2021.
5
The amygdalar opioid system.杏仁核阿片系统。
Handb Behav Neurosci. 2020;26:161-212. doi: 10.1016/B978-0-12-815134-1.00008-8. Epub 2020 Mar 31.
6
Mice Lacking GABA Receptor Subunit Have Altered Pharmaco-EEG Responses to Multiple Drugs.缺乏γ-氨基丁酸受体亚基的小鼠对多种药物的药物脑电图反应发生改变。
Front Pharmacol. 2021 Jun 21;12:706894. doi: 10.3389/fphar.2021.706894. eCollection 2021.
7
Early Life Stress and Risks for Opioid Misuse: Review of Data Supporting Neurobiological Underpinnings.早期生活压力与阿片类药物滥用风险:支持神经生物学基础的数据综述
J Pers Med. 2021 Apr 19;11(4):315. doi: 10.3390/jpm11040315.
8
Mu opioid receptor regulation of glutamate efflux in the central amygdala in response to predator odor.μ阿片受体对捕食者气味作出反应时中央杏仁核中谷氨酸外流的调节。
Neurobiol Stress. 2019 Oct 14;11:100197. doi: 10.1016/j.ynstr.2019.100197. eCollection 2019 Nov.
9
Activation of enkephalinergic (Enk) interneurons in the central amygdala (CeA) buffers the behavioral effects of persistent pain.中脑杏仁核(CeA)内啡肽能(Enk)中间神经元的激活缓冲了持续性疼痛的行为影响。
Neurobiol Dis. 2019 Apr;124:364-372. doi: 10.1016/j.nbd.2018.12.005. Epub 2018 Dec 17.
10
IL-1 interacts with ethanol effects on GABAergic transmission in the mouse central amygdala.白细胞介素-1与乙醇对小鼠中央杏仁核中γ-氨基丁酸能传递的影响相互作用。
Front Pharmacol. 2015 Mar 19;6:49. doi: 10.3389/fphar.2015.00049. eCollection 2015.
Effects of acute ethanol on opioid peptide release in the central amygdala: an in vivo microdialysis study.
急性乙醇对中央杏仁核中阿片肽释放的影响:一项体内微透析研究。
Psychopharmacology (Berl). 2008 Dec;201(2):261-71. doi: 10.1007/s00213-008-1267-8. Epub 2008 Aug 8.
4
Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction.细胞对慢性阿片类药物的神经适应性变化:耐受性、戒断反应与成瘾
Br J Pharmacol. 2008 May;154(2):384-96. doi: 10.1038/bjp.2008.100. Epub 2008 Apr 14.
5
Morphine-induced analgesic tolerance, locomotor sensitization and physical dependence do not require modification of mu opioid receptor, cdk5 and adenylate cyclase activity.吗啡诱导的镇痛耐受性、运动敏化和身体依赖性并不需要改变μ阿片受体、cdk5和腺苷酸环化酶的活性。
Neuropharmacology. 2008 Mar;54(3):475-86. doi: 10.1016/j.neuropharm.2007.10.015. Epub 2007 Nov 5.
6
The amygdala.杏仁核。
Curr Biol. 2007 Oct 23;17(20):R868-74. doi: 10.1016/j.cub.2007.08.005.
7
Characterization of neurons in the rat central nucleus of the amygdala: cellular physiology, morphology, and opioid sensitivity.大鼠杏仁核中央核神经元的特征:细胞生理学、形态学及阿片类敏感性
J Comp Neurol. 2006 Aug 20;497(6):910-27. doi: 10.1002/cne.21025.
8
Effects of recurrent withdrawal on spinal GABA release during chronic morphine infusion in the rat.反复撤药对大鼠慢性吗啡输注期间脊髓γ-氨基丁酸释放的影响。
Eur J Pharmacol. 2006 Mar 27;535(1-3):152-6. doi: 10.1016/j.ejphar.2006.02.007. Epub 2006 Mar 15.
9
Mu-opioid-mediated inhibition of glutamate synaptic transmission in rat central amygdala neurons.μ-阿片类物质介导的对大鼠中央杏仁核神经元谷氨酸突触传递的抑制作用。
Neuroscience. 2005;133(1):97-103. doi: 10.1016/j.neuroscience.2005.02.004.
10
Modulation of morphine-induced Fos-immunoreactivity by the cannabinoid receptor antagonist SR 141716.大麻素受体拮抗剂SR 141716对吗啡诱导的Fos免疫反应性的调节作用
Neuropharmacology. 2004 Dec;47(8):1157-69. doi: 10.1016/j.neuropharm.2004.08.008.